Home

Kelly Blackburn

CIK 1640575 · EVP, Clinical Development · last filed 2026-02-13

Kelly Blackburn is an EVP, Clinical Development who has filed 9 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for CRVO, was dated Feb 13, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

9

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRVO EVP, Clinical Development — $2.45 — $0 4 2026-02-13
LIFE VP, Clinical Affairs — $15.61 — $0 5 2016-03-30

Recent Filings

9 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-13 CRVO Grant (A) — $0 EDGAR
2025-02-14 CRVO Grant (A) — $0 EDGAR
2024-01-26 CRVO Grant (A) — $0 EDGAR
2023-09-15 CRVO Grant (A) — $0 EDGAR
2016-03-30 LIFE Grant (A) — $0 EDGAR
2016-01-29 LIFE Grant (A) — $0 EDGAR
2016-01-06 LIFE Grant (A) — $0 EDGAR
2015-10-05 LIFE Grant (A) — $0 EDGAR
2015-05-08 LIFE Grant (A) — $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.